Odyssey Health, Inc.
ODYY
$0.01
$0.00-5.56%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 130.52% | 16.16% | -47.67% | 168.65% | -65.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.52% | 16.16% | -47.67% | 165.59% | -65.33% |
| Operating Income | -130.52% | -16.16% | 47.67% | -165.59% | 65.33% |
| Income Before Tax | 404.29% | -1,536.35% | 52.56% | 98.02% | 70.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 404.29% | -1,536.35% | 52.56% | 98.02% | 70.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 404.29% | -1,536.35% | 52.56% | 98.02% | 70.12% |
| EBIT | -130.52% | -16.16% | 47.67% | -165.59% | 65.33% |
| EBITDA | -- | -- | -- | -165.42% | 65.44% |
| EPS Basic | 395.83% | -1,490.48% | 52.58% | 98.03% | 70.37% |
| Normalized Basic EPS | 454.55% | -1,507.69% | 28.21% | -244.44% | 62.07% |
| EPS Diluted | 375.00% | -1,490.48% | 54.00% | 92.12% | 76.00% |
| Normalized Diluted EPS | 309.09% | -1,507.69% | 28.21% | -244.44% | 62.07% |
| Average Basic Shares Outstanding | 3.17% | 3.00% | 1.27% | -0.05% | 0.89% |
| Average Diluted Shares Outstanding | 78.28% | 3.00% | 1.27% | -0.05% | 0.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |